Shanda Asset Management Holdings’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,500
| Closed | -$42K | – | 37 |
|
|
2019
Q2 | $42K | Hold |
2,500
| – | – | 0.01% | 30 |
|
|
2019
Q1 | $42K | Hold |
2,500
| – | – | 0.01% | 49 |
|
|
2018
Q4 | $29K | Hold |
2,500
| – | – | 0.01% | 50 |
|
|
2018
Q3 | $100K | Hold |
2,500
| – | – | 0.02% | 35 |
|
|
2018
Q2 | $71K | Hold |
2,500
| – | – | 0.01% | 46 |
|
|
2018
Q1 | $38K | Hold |
2,500
| – | – | 0.01% | 38 |
|
|
2017
Q4 | $82K | Hold |
2,500
| – | – | 0.01% | 44 |
|
|
2017
Q3 | $59K | Hold |
2,500
| – | – | 0.01% | 38 |
|
|
2017
Q2 | $14K | Hold |
2,500
| – | – | ﹤0.01% | 33 |
|
|
2017
Q1 | $18K | Hold |
2,500
| – | – | ﹤0.01% | 34 |
|
|
2016
Q4 | $10K | Hold |
2,500
| – | – | ﹤0.01% | 28 |
|
|
2016
Q3 | $18K | Buy |
+2,500
| New | +$18K | ﹤0.01% | 25 |
|